Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Meyer

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Rheumatology (Oxford, England)|October 5, 2023
Comment on: Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective studyMargherita Giannini, Alain Meyer
Neurology|December 1, 2020
Author response: Granulomatosis-associated myositis: High prevalence of sporadic inclusion body myositisYannick Dieudonné, Alain Meyer
Joint Bone Spine|February 4, 2019
Strategy for suspected myositisAlain Meyer, Jean Sibilia
Annals of the Rheumatic Diseases|December 6, 2019
Response to: 'Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients' by Ogawa-Momohara <i>et al</i>Lionel Spielmann, Benoit Nespola, Alain Meyer
Annals of the Rheumatic Diseases|March 28, 2020
Response to: 'Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies' by Yang <i>et al</i>Lionel Spielmann, Benoit Nespola, Alain Meyer
Annals of the Rheumatic Diseases|August 16, 2015
In the idiopathic inflammatory myopathies, reactive oxygen species are at the crossroad between immune and non-immune cell-mediated mechanismsAlain Meyer, Jean Sibilia, Bernard Geny
Annals of the Rheumatic Diseases|August 19, 2019
Response to: 'On using machine learning algorithms to define clinically meaningful patient subgroups' by Knevel and HuizingaAlain Meyer, Lionel Spielmann, François Séverac
Annals of the Rheumatic Diseases|September 22, 2019
Response to: 'Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis' by Campochiaro <i>et al</i>Lionel Spielmann, François Séverac, Alain Meyer
Annals of the Rheumatic Diseases|July 26, 2019
On how to not misuse hierarchical clustering on principal components to define clinically meaningful patient subgroups. Response to: 'On using machine learning algorithms to define clinical meaningful patient subgroups' by Pinal-Fernandez and MammenAlain Meyer, Lionel Spielmann, François Séverac
Clinical and Experimental Rheumatology|June 29, 2026
Comment on: Mitochondrial abnormalities in idiopathic inflammatory myopathies by Torri et al.: a short reader guideMargherita Giannini, Bernard Geny, Alain Meyer
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Rheumatology (Oxford, England)|October 5, 2023
Comment on: Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective studyMargherita Giannini, Alain Meyer
Neurology|December 1, 2020
Author response: Granulomatosis-associated myositis: High prevalence of sporadic inclusion body myositisYannick Dieudonné, Alain Meyer
Joint Bone Spine|February 4, 2019
Strategy for suspected myositisAlain Meyer, Jean Sibilia
Annals of the Rheumatic Diseases|December 6, 2019
Response to: 'Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients' by Ogawa-Momohara <i>et al</i>Lionel Spielmann, Benoit Nespola, Alain Meyer
Annals of the Rheumatic Diseases|March 28, 2020
Response to: 'Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies' by Yang <i>et al</i>Lionel Spielmann, Benoit Nespola, Alain Meyer
Annals of the Rheumatic Diseases|August 16, 2015
In the idiopathic inflammatory myopathies, reactive oxygen species are at the crossroad between immune and non-immune cell-mediated mechanismsAlain Meyer, Jean Sibilia, Bernard Geny
Annals of the Rheumatic Diseases|August 19, 2019
Response to: 'On using machine learning algorithms to define clinically meaningful patient subgroups' by Knevel and HuizingaAlain Meyer, Lionel Spielmann, François Séverac
Annals of the Rheumatic Diseases|September 22, 2019
Response to: 'Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis' by Campochiaro <i>et al</i>Lionel Spielmann, François Séverac, Alain Meyer
Annals of the Rheumatic Diseases|July 26, 2019
On how to not misuse hierarchical clustering on principal components to define clinically meaningful patient subgroups. Response to: 'On using machine learning algorithms to define clinical meaningful patient subgroups' by Pinal-Fernandez and MammenAlain Meyer, Lionel Spielmann, François Séverac
Clinical and Experimental Rheumatology|June 29, 2026
Comment on: Mitochondrial abnormalities in idiopathic inflammatory myopathies by Torri et al.: a short reader guideMargherita Giannini, Bernard Geny, Alain Meyer
Pageof 22